Samantha Greenberg, M.S.

Internal Medicine - Hematology/Oncology

Biography

Samantha Greenberg, Ph.D., M.S., M.P.H., CGC, is a certified genetic counselor who provides clinical cancer genetic services. As a cancer genetic counselor, she has provided clinical care across a variety of indications and facilitated the development of multidisciplinary teams and genetics clinics for patients with prostate cancer, von Hippel-Lindau syndrome, and paraganglioma/pheochromocytoma.

Dr. Greenberg's research focuses on access to genetic testing and outcomes, including prostate cancer and paraganglioma/pheochromocytoma. She received her Ph.D. in nursing from the University of Utah College of Nursing, a Master of Science in Genetic Counseling, and a Master of Public Health from the University of Michigan.

Education & Training

Undergraduate School - University of Michigan (2007-2011)
Graduate School - University of Michigan (2013-2016), Genetic Counseling
Graduate School - University of Michigan School of Public Health (2013-2016), Public Health
Graduate School - University of Utah College of Nursing (2020-2024)

Professional Associations & Affiliations

National Society of Genetic Counselors
American Society of Clinical Oncology
North American Neuroendocrine Tumor Society
American Board of Genetic Counseling

Honors & Awards

Outstanding Teacher Award 2021, University of Utah Graduate Program in Genetic Counseling
Outstanding Supervisor Award 2021, University of Michigan Genetic Counseling Program
Journal of Urology 2023, Reviewer of the Month
Public Health Genetics Fellowship 2015, University of Michigan School of Public Health

Books & Publications

Publications
- The Natural History of Observed SDHx-Related Head and Neck Paragangliomas Using Three-Dimensional Volumetric Tumor Analysis.
  Tooker EL, Wiggins RH, Espahbodi M, Naumer A, Buchmann LO, Greenberg SE, Patel NS, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2023 Aug
- A need to tailor surveillance based on family history: describing a highly penetrant familial paraganglioma kindred with an SDHD pathogenic variant.
  Foley M, Sharma A, Garfield K, Maese L, Buchmann L, Boyle J, Kohlmann W, Jeter J, Greenberg S, Familial cancer 2023 Apr 22 2 217-224
- Initial outcomes and insights from a novel high-risk prostate cancer screening clinic.
  Harper JB, Greenberg SE, Hunt TC, Cooney KA, O'Neil BB, The Prostate 2023 Feb 83 2 151-157
- Prostate Cancer Genomic Testing: When Sequencing Is Not Sufficient and Germline Testing Is Necessary.
  Jacobs MF, Greenberg SE, European urology 2023 Jan 83 1 39-40
- Editorial Comment.
  Greenberg S, The Journal of urology 2022 Nov 208 5 1016
- Discrepancies between tumor genomic profiling and germline genetic testing.
  Pauley K, Koptiuch C, Greenberg S, Kohlmann W, Jeter J, Colonna S, Werner T, Kinsey C, Gilcrease G, Weis J, Whisenant J, Florou V, Garrido-Laguna I, ESMO open 2022 Aug 7 4 100526
- Continuing the Evolution of Germline Genetics in Prostate Cancer: Tailoring Testing To Enhance Patient Care.
  Greenberg SE, Jacobs MF, European urology 2022 Jun 81 6 568-569
- Inherited TP53 Variants and Risk of Prostate Cancer.
  Maxwell KN, Cheng HH, Powers J, Gulati R, Ledet EM, Morrison C, Le A, Hausler R, Stopfer J, Hyman S, Kohlmann W, Naumer A, Vagher J, Greenberg SE, Naylor L, Laurino M, Konnick EQ, Shirts BH, AlDubayan SH, Van Allen EM, Nguyen B, Vijai J, Abida W, Carlo MI, Dubard-Gault M, Lee DJ, Maese LD, Mandelker D, Montgomery B, Morris MJ, Nicolosi P, Nussbaum RL, Schwartz LE, Stadler Z, Garber JE, Offit K, Schiffman JD, Nelson PS, Sartor O, Walsh MF, Pritchard CC, European urology 2022 Mar 81 3 243-250
- Paraganglioma and other tumour detection rates in individuals with SDHx pathogenic variants by age of diagnosis and after the age of 50.
  Greenberg SE, Holman R, Kohlmann W, Buchmann L, Naumer A, Clinical endocrinology 2021 Sep 95 3 447-452
- Implementing innovative service delivery models in genetic counseling: a qualitative analysis of facilitators and barriers.
  Khan A, Cohen S, Weir C, Greenberg S, Journal of genetic counseling 2021 Feb 30 1 319-328
- Genetic counseling service delivery models: A study of genetic counselors' interests, needs, and barriers to implementation.
  Boothe E, Greenberg S, Delaney CL, Cohen SA, Journal of genetic counseling 2021 Feb 30 1 283-292
- Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion.
  Greenberg SE, Hunt TC, Ambrose JP, Lowrance WT, Dechet CB, O'Neil BB, Tward JD, JCO precision oncology 2021 5
- Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome.
  Greenberg SE, Jacobs MF, Wachtel H, Anson A, Buchmann L, Cohen DL, Bonanni M, Bennett B, Naumer A, Schaefer AM, Kohlmann W, Nathanson KL, Else T, Fishbein L, Genetics in medicine : official journal of the American College of Medical Genetics 2020 Dec 22 12 2101-2107
- Genetic Counseling Service Delivery Models in the United States: Assessment of changes in use from 2010 to 2017.
  Greenberg SE, Boothe E, Delaney CL, Noss R, Cohen SA, Journal of genetic counseling 2020 Dec 29 6 1126-1141
- What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing.
  Greenberg S, Slager S, Neil BO, Cooney K, Maughan B, Stopa N, Venne V, Zickmund S, Colonna S, The Prostate 2020 Apr 80 5 441-450
- Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer.
  Boyle JL, Hahn AW, Kapron AL, Kohlmann W, Greenberg SE, Parnell TJ, Teerlink CC, Maughan BL, Feng BJ, Cannon-Albright L, Agarwal N, Cooney KA, JCO precision oncology 2020 4
- Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.
  Greenberg S, Buys SS, Edwards SL, Espinel W, Fraser A, Gammon A, Hafen B, Herget KA, Kohlmann W, Roundy C, Sweeney C, Cancer medicine 2019 Nov 8 15 6789-6798

Research

Prostate cancer genetic access
Paraganglioma genetics
Mentorship and Career Transitions

New Patient Appointment or 214-645-4673